Usefulness of urine dipstick test in the management of adverse events associated with immune checkpoint inhibitors

Support Care Cancer. 2024 Oct 18;32(11):735. doi: 10.1007/s00520-024-08928-y.

Abstract

Purpose: The usefulness of urine dipstick tests (UDTs) in patients with diabetes has been reported. The aim of the present study was to investigate the utility of self-performed UDTs and patient diaries in the management of impaired glucose tolerance, one of the adverse events of immune checkpoint inhibitors (ICIs).

Methods: Patients receiving ICIs underwent self-checks with UDTs twice a week for up to 6 months. Pharmacists checked the results at every patient visit, and by phone every 3 months. The primary endpoint was to prospectively assess whether symptoms recorded in patient diaries and UDTs could reduce unscheduled hospital admissions due to impaired glucose tolerance. The secondary endpoint was the correlation between the symptoms in the patient diaries and UDT results.

Results: A total of 112 patients were enrolled in the study. Out of the 3197 planned self-UDTs, 3128 (97.8%) were performed. Forty-four patients (39.3%) were admitted to the hospital, two (1.8%) of whom were admitted due to abnormal glucose tolerance, with one having a positive UDT. There were 46 unscheduled outpatient visits (41.1%), of which five (4.5%) were due to abnormal glucose tolerance symptoms and four were due to a positive UDT. The correlation between descriptions of fatigue or dry mouth in the patient diaries and positive glucose UDTs was 52.4% in sensitivity and 62.4% in specificity.

Conclusion: Self-monitoring of symptoms and self-performing of UDTs could not reduce the emergency hospitalization rate. However, this approach could be effective in the objective monitoring of patient status, especially regarding glucose intolerance occurrences.

Keywords: Immune checkpoint inhibitor; Patient’s diary; Pharmacist; Telephone follow-up; Urine dipstick test.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Glucose Intolerance
  • Humans
  • Immune Checkpoint Inhibitors* / adverse effects
  • Male
  • Middle Aged
  • Neoplasms / drug therapy
  • Prospective Studies
  • Urinalysis / methods

Substances

  • Immune Checkpoint Inhibitors